Centrul de Oncologie Sf. Nectarie

Craiova, Dolj 200746

3 studies enrolling now · 7 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Breast Cancer, Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Metastatic Breast Cancer, Patients With Non-Small Cell Lung Cancer, Well-differentiated Pancreatic Neuroendocrine Tumor

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02) — Completed
• A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors — Completed